Psychiatry and Neurology, Neurology · Tyler, TX
NPI
1235103201
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
910 E Houston St, Ste 330
Tyler, TX, 75702
Phone (903) 510-8848
Groups this clinician bills Medicare through
Medicare paid, 2024
$156K
2,690 services
Medicare patients, 2024
582
Average age 71
Drug cost, 2024
$7.6M
9,512 prescriptions
Company payments, 2025
$2,546
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by George W Kariampuzha was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 541 times for 377 patients. In total George W Kariampuzha billed 2,690 services in 68 codes, and Medicare paid $156K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-12.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 541 | 377 | $12.49 | $6,760 |
| 99215 Office E&M - Established | Facility | 326 | 233 | $105.58 | $34K |
| 99214 Office E&M - Established | Facility | 315 | 246 | $68.39 | $22K |
| 95886 Electrical Nerve Conductivity | Facility | 297 | 99 | $34.16 | $10K |
| G0453 Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | Facility | 249 | 35 | $25.14 | $6,259 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 126 | 112 | $24.53 | $3,091 |
| 64616 Musculoskeletal | Facility | 111 | 46 | $119.29 | $13K |
| 99205 Office E&M - New | Facility | 90 | 90 | $125.52 | $11K |
| 95913 Electrical Nerve Conductivity | Facility | 73 | 73 | $136.54 | $9,968 |
| 95720 Neurologic | Facility | 65 | 27 | $156.77 | $10K |
| 99213 Office E&M - Established | Facility | 40 | 39 | $44.51 | $1,780 |
| 95861 Electrical Nerve Conductivity | Facility | 39 | 39 | $63.07 | $2,460 |
| 99231 Hospital E&M - Subsequent | Facility | 35 | 21 | $37.38 | $1,308 |
| 95938 Electrical Nerve Conductivity | Facility | 35 | 34 | $35.26 | $1,234 |
| 95816 Neurologic | Facility | 31 | 31 | $42.15 | $1,307 |
By year: 2022 $139K for 1,931 services; 2023 $147K for 1,922 services; 2024 $156K for 2,690 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 23 | 19 | $8.65 | $199 |
Medicare prescription drug claims, 2024
In 2024, the drug George W Kariampuzha prescribed most often to Medicare patients was Memantine Hcl, with 662 prescriptions and refills. In total George W Kariampuzha wrote 9,512 Medicare prescriptions that cost $7.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 662 | 1,056 | 133 | $16K |
| Gabapentin Generic | 627 | 847 | 133 | $11K |
| Topiramate Generic | 550 | 828 | 100 | $6,604 |
| Levetiracetam Generic | 523 | 891 | 102 | $13K |
| Pregabalin Generic | 297 | 321 | 62 | $5,391 |
| Lacosamide Generic | 264 | 279 | 55 | $16K |
| Clopidogrel Clopidogrel Bisulfate | 232 | 414 | 52 | $2,072 |
| Clonazepam Generic | 231 | 235 | 39 | $3,753 |
| Zonisamide Generic | 226 | 341 | 49 | $5,162 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 188 | 274 | 47 | $3,239 |
| Donepezil Hcl Generic | 185 | 316 | 35 | $1,418 |
| Divalproex Sodium Generic | 178 | 259 | 31 | $5,610 |
| Qulipta Atogepant | 172 | 196 | 40 | $205K |
| Lamotrigine Generic | 172 | 226 | 22 | $2,577 |
| Trazodone Hcl Generic | 168 | 230 | 36 | $942 |
Brand drugs: 1,239 claims; generic drugs: 8,225 claims; opioid claims: 97.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid George W Kariampuzha $2,546 ($2,546 in general payments such as food, travel and fees) from 9 companies. The largest payer was LivaNova USA, Inc. with $1,809.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.